Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan
- PMID: 28771894
- PMCID: PMC5655764
- DOI: 10.1111/hel.12415
Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan
Abstract
Background: In Japan, there have been approximately 50 000 deaths from gastric cancer annually for over 40 years with little variation. It has been reported that most gastric cancers in Japan are caused by Helicobacter pylori infection. H. pylori eradication therapy was approved for patients with chronic gastritis by the Japanese national health insurance scheme in February 2013 for patients with an endoscopic diagnosis of chronic gastritis is positive for H. pylori. We examined the effect on gastric cancer death rate 4 years after expansion of health insurance coverage.
Aim: We conducted an epidemiological study and analyzed trends in prescription for H. pylori eradication therapy. We used the electronic medical claims database from Hokkaido, Japan to evaluate the impact of expansion of national health insurance coverage for H. pylori eradication therapy on deaths from gastric cancer.
Methods: Data on deaths from gastric cancer were obtained from the Japanese Ministry of Health, Labour and Welfare and the Cancer Statistics in Japan (2015). Analysis of electronic claims records was performed using the National Database, mainly focusing on Hokkaido. Prescriptions for H. pylori eradication therapy and the number of patients treated for gastric cancer were also extracted from the Hokkaido database.
Results: Approximately 1.5 million prescriptions for H. pylori eradication therapy were written annually. Gastric cancer deaths fell each year: 48 427 in 2013, 47 903 in 2014, 46 659 in 2015, and 45 509 in 2016, showing a significant decrease after expansion of insurance coverage for H. pylori eradication therapy (P<.0001).
Conclusions: Prescriptions for H. pylori eradication therapy increased markedly after approval of the gastritis indication by the national health insurance scheme and was associated with a significant decrease in gastric cancer deaths.
Keywords: gastric cancer; gastric cancer deaths; prevention of gastric cancer.
© 2017 The Authors. Helicobacter Published by John Wiley & Sons Ltd.
Figures
Similar articles
-
Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan.J Gastroenterol. 2014 Jan;49(1):1-8. doi: 10.1007/s00535-013-0897-8. Epub 2013 Oct 27. J Gastroenterol. 2014. PMID: 24162382 Free PMC article. Review.
-
Gastric cancer deaths by age group in Japan: Outlook on preventive measures for elderly adults.Cancer Sci. 2020 Oct;111(10):3845-3853. doi: 10.1111/cas.14586. Epub 2020 Aug 18. Cancer Sci. 2020. PMID: 32713120 Free PMC article.
-
Impact of health insurance coverage for Helicobacter pylori gastritis on the trends in eradication therapy in Japan: retrospective observational study and simulation study based on real-world data.BMJ Open. 2017 Jul 31;7(7):e015855. doi: 10.1136/bmjopen-2017-015855. BMJ Open. 2017. PMID: 28760790 Free PMC article.
-
Helicobacter pylori Eradication to Eliminate Gastric Cancer: The Japanese Strategy.Gastroenterol Clin North Am. 2015 Sep;44(3):639-48. doi: 10.1016/j.gtc.2015.05.010. Epub 2015 Jul 15. Gastroenterol Clin North Am. 2015. PMID: 26314673 Review.
-
An increasing trend of gastric cancer deaths and inadequate preventive measures in elderly adults.Helicobacter. 2023 Aug;28(4):e12988. doi: 10.1111/hel.12988. Epub 2023 May 29. Helicobacter. 2023. PMID: 37246819
Cited by
-
Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States.Clin Gastroenterol Hepatol. 2018 Jul;16(7):992-1002.e6. doi: 10.1016/j.cgh.2018.03.013. Epub 2018 Mar 17. Clin Gastroenterol Hepatol. 2018. PMID: 29559361 Free PMC article.
-
Helicobacter Pylori Infection Induces Intestinal Dysbiosis That Could Be Related to the Onset of Atherosclerosis.Biomed Res Int. 2022 Oct 22;2022:9943158. doi: 10.1155/2022/9943158. eCollection 2022. Biomed Res Int. 2022. PMID: 36317116 Free PMC article. Review.
-
H. pylori Infection and Virulence Factors cagA and vacA (s and m Regions) in Gastric Adenocarcinoma from Pará State, Brazil.Pathogens. 2022 Mar 29;11(4):414. doi: 10.3390/pathogens11040414. Pathogens. 2022. PMID: 35456089 Free PMC article.
-
Novel epigenetic markers for gastric cancer risk stratification in individuals after Helicobacter pylori eradication.Gastric Cancer. 2018 Sep;21(5):745-755. doi: 10.1007/s10120-018-0803-4. Epub 2018 Feb 9. Gastric Cancer. 2018. PMID: 29427040
-
Gastric cancer: Epidemiology, risk factors and prevention strategies.Chin J Cancer Res. 2020 Dec 31;32(6):695-704. doi: 10.21147/j.issn.1000-9604.2020.06.03. Chin J Cancer Res. 2020. PMID: 33446993 Free PMC article.
References
-
- Blaser MJ. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis. 1990;161:626‐633. - PubMed
-
- Asaka M, Sugiyama T, Nobuta A, Kato M, Takeda H, Graham DY. Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study. Helicobacter. 2001;6:294‐299. - PubMed
-
- Dooley CP, Cohen H, Fitzgibbons PL, et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med. 1989;21:1562‐1566. - PubMed
-
- Drumm B, Sherman P, Cutz E, Karmali M. Association of Campylobacter pylori on the gastric mucosa with antral gastritis in children. N Engl J Med. 1987;316:1557‐1561. - PubMed
-
- Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161‐1181. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical